Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000899243-16-022431
Filing Date
2016-06-10
Accepted
2016-06-10 16:21:02
Documents
1
Period of Report
2016-06-09

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 4004
  Complete submission text file 0000899243-16-022431.txt   5344
Mailing Address 201 ELLIOTT AVENUE WEST SEATTLE WA 98119
Business Address 201 ELLIOTT AVENUE WEST SEATTLE WA 98119 206-676-5000
OMEROS CORP (Issuer) CIK: 0001285819 (see all company filings)

EIN.: 911663741 | State of Incorp.: WA | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O ARCADIA BIOSCIENCES, INC. 202 COUSTEAU PLACE, SUITE 105 DAVIS CA 95618
Business Address
Shah Rajiv (Reporting) CIK: 0001642407 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-34475 | Film No.: 161708886